PRF1 as a prognostic gene for lymphatic metastasis in skin melanoma
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Yufu Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China; Clinical Research Center for Precision Medicine of Abdominal Tu…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Lymphatic Metastasis, Perforin. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Melanoma is a highly aggressive tumor, predominantly found in the skin, recognized as skin cutaneous melanoma (SKCM). Lymph node metastasis is commonly used as the route of metastasis in SKCM, necessitating the discovery of prognostic genes associated with this process for improved prognosis. METHODS: The prognostic significance of lymph node metastasis in SKCM was assessed through Kaplan-Meier analysis in SEER and TCGA-SKCM datasets. Prognostic genes were identified and a prognostic risk model was constructed Enrichment analysis and immune cell infiltration analysis were also carried out.Moreover, a validation in vitro and in vivo were conducted by CCK8,flow cytometry, transwell and animal study. RESULTS: The Kaplan-Meier survival curve revealed that patients with lymph node metastasis had a worse prognosis compared to those without. FCGR3B and PRF1 were screened by TCGA analysis.Additionally, significant differences in nine immune cell types were observed between the two risk groups. Notably, a strong positive association with CD8 T cells and a negative relationship with M2 macrophages were exhibited by PRF1. The validation of our nomogram were conducted in vitro and in vivo, and the results showed the correlations between CD8+ T cell and PRF1. CONCLUSION: In summary, two prognostic genes (FCGR3B and PRF1) were identified, and a prognostic risk model was developed for SKCM. These findings provide a novel approach for the diagnosis and treatment of SKCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China; Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, China.
- Department of General Practice, Zhongshan Hospital (Xiamen), Fudan University, China.
- Department of Integrated Traditional Chinese and Western Medicine, Zhongshan Hospital (Xiamen), Fudan University, China.
- Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, China; Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University, China; Department of Radiation Oncology, Zhongshan Hos…
- Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China; Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, China; Department of Medical Oncology, Zhongsh…
Zitieren
APA
Lin, Y., Liu, J., Chen, S., Wu, Q., Shen, F., & Gan, L. (2024). PRF1 as a prognostic gene for lymphatic metastasis in skin melanoma. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150338
Vancouver
Lin Y, Liu J, Chen S, Wu Q, Shen F, Gan L. PRF1 as a prognostic gene for lymphatic metastasis in skin melanoma. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150338
BibTeX
@article{Lin2024,
author = {Lin, Yufu and Liu, Jia and Chen, Shaozhuang and Wu, Qiqiao and Shen, Feng and Gan, Lu},
title = {PRF1 as a prognostic gene for lymphatic metastasis in skin melanoma},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150338}
}
EUVIMED